科学图书馆
-
Coronary flow velocity reserve predicts adverse prognosis in women with angina and noobstructive coronary artery disease: resultsfrom the iPOWER studyJ Schroder, MM Michelsen, ND Mygind et al. -
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart AssociationCB Newman and and on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council.
-
2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)he management of patients with)J Brugada, DG Katritsis, ESC Scientific Document Group et al.
-
Select Drug-Drug Interactions With Direct Oral AnticoagulantsBS Wiggins, DL Dixon, RR Neyens et al.
-
Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratoryKlein LW, Kern MJ, Interventional Cardiology Committee of the Society of Cardiac Angiography and Interventions.
-
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast mediaAzzalini L, Vilca LM, Lombardo F et al.
-
Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural managementD Cao, R Chandiramani, R Mehran et al.
-
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary InterventionBrilakis ES, Mashayekhi K, Tsuchikane E et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
